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Abstract
Isolated systolic hypertension (ISH) is a major contributor to cardiovascular 
disease morbidity and mortality worldwide, however, diagnosis of ISH is mainly 
dependent on conventional blood pressure (BP) techniques. Studies that have used 
ambulatory blood pressure monitoring (ABPM) were only limited to 24-hour BP. 
To date ambulatory isolated BP subtypes have never been identified. Therefore, the 
prevalence of ambulatory subtypes of ISH unknown. Conventional and ambulatory 
BP was measure in 549 participants and based on the results, they were strati-
fied into ISH subtypes (Conventional, Daytime, Night-time and 24-hour ISH). 
Participants further underwent measurements of pulse wave velocity (PWV) and 
left ventricular mass index (LVMI) to determine the extent of arterial stiffness and 
left ventricular hypertrophy. We further assessed whether the target organ changes 
are associated with any ISH subtype. The prevalence of Conventional ISH (ISHC), 
24-hour ISH (ISH24), Night-time ISH (ISHN) and Daytime ISH (ISHD) was 7.5%, 
7.1%, 7.7% and 7.5% respectively. Compared to normotensives, all ISH subtypes had 
higher PWV and LVMI. These target organ changes were similar to those observed 
in hypertensives. Our results indicate that isolated systolic hypertension, whether 
conventional or ambulatory, is as detrimental as hypertension on cardiovascular 
target organs.
Keywords: hypertension, hypertrophy, ambulatory nocturnal, conventional, 
cardiovascular
1. Introduction
By definition, hypertension is a chronic condition characterised by persistent 
elevated blood pressure [1]. Traditionally, the term hypertension has been used to 
describe a condition in which systolic BP (SBP) is equal or above 140 mm Hg and/
or a diastolic BP (DBP) is equal or above 90 mm Hg [2]. The term Systolic-diastolic 
hypertension (SDH) is slowly replacing ‘hypertension’ in this regard as the latter 
becomes a broader term describing a large number of classes/categories of persis-
tent high BP [3–5]. Thus hypertension can be divided into several types based on 
several criteria which may or may not overlap.
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European Society of Cardiology/European Society of Hypertension (ESC/ESH) 
criteria for the classification of participants according to office (conventional) BP 
measurement [4].
The America College of cardiology/American Heart Society (ACC/AHA) has 
more stringent criteria for conventional BP diagnosis of the hypertension categories.
The advent of ambulatory BP monitoring (ABPM) has revealed much about 
other subtypes of hypertension in everyday environments; in fact, some developed 
countries have called for the application of ABPM as a routine tool in clinical 
practice [6–9]. The superiority of this technique over office BP measurement has 
been well documented, particularly with respect to the prediction of cardiovascular 
events and target organ damage [10, 11]. Another benefit of this method is that it 
minimises the interference of false BP elevations/reductions that may be influenced 
by clinical settings or other stimuli, as the case may be with white coat hypertension 
or masked hypertension [10, 12].
The ABPM technique has been instrumental in the understanding of circadian 
rhythm of haemodynamics, in particular the phenomena of night-time BP dipping 
or rising, the early morning BP surge [13] as well as BP variability [8, 12]. In light of 
all these advantages, it is not surprising that ambulatory techniques are now consid-
ered the gold standard in hypertension diagnosis and out of office BP measurement 
[9, 14]. In fact, the ESH and ESC guidelines recommend that wherever possible this 
method be used as the basis for hypertension diagnosis [2].
The ESC/ESH and ACC/AHA thresholds for hypertension diagnosis according to 
ABPM [2, 15].
Using the above ambulatory blood pressure thresholds, the following subtypes 
of hypertension have been identified:
Category SBP (mm Hg) DBP (mm Hg)
Normal (Normotensive) 120–129 and/or 80–84
High-Normal (Normotensive) 130–139 and/or 85–89
Hypertensive ≥ 140 and/or ≥ 90
Isolated Systolic Hypertensive ≥ 140 and ≤ 90
Isolated Diastolic Hypertensive ≤ 140 and ≥ 90
Category SBP (mm Hg) DBP (mm Hg)
Normal (Normotensive) < 120 and < 80
Elevated (High-Normal) 120–129 and <80
Grade 1 Hypertension 130–139 and/or 80–90
Grade 2 Hypertension ≥ 140 and/or ≥ 90
Isolated Systolic Hypertensive ≥ 130 and < 80
Isolated Diastolic Hypertension < 130 and ≥ 80
Category SBP (mm Hg) DBP (mm Hg)
Daytime mean ≥ 135 and/or ≥ 85
Night-time mean ≥ 120 and/or ≥ 70
24 hour mean ≥ 130 and/or ≥ 80
3
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Ambulatory BP has also allowed identification of two abnormal night-time 
blood pressure patterns. The first one is an attenuated decline in nocturnal BP. 
Blood pressure varies over 24 hours, it is high during the day and low during the 
night. Normally, BP decreases by 10% to 20% during the night. Individuals that 
lack this decline in nocturnal BP are classified as non-dippers. A large body of 
evidence exists around the strong association between a non-dipping profile and 
target organ damage at a vascular, cardiac and cerebrovascular level. Another 
variant BP pattern that is opposite to non-dipping has been identified with 
ambulatory BP monitoring. Individuals who present with this condition have 
an abnormally high night-time BP that rises above the daytime BP values. This 
condition known as reverse dipping has also been associated with cardiovascular 
target organ damage.
1.1 Isolated systolic hypertension
Isolated Systolic Hypertension is a form of hypertension characterised by 
elevated SBP ≥ 140 mm Hg and often normal or low DBP < 90 mm Hg [16]. As a 
result of this, ISH is associated with increased pulse pressure (PP), which is the 
difference between SBP and DBP [16, 17]. Previous studies of ISH date as far back 
as 1970 [18], with interest in the subject increasing around the 1980’s [19–22]. Most 
of these earlier studies identified ISH as a disease of the elderly, stemming from the 
“normal” physiological processes associated with ageing [20, 22, 23]. More recent 
studies have revealed that ISH does in fact also exist in younger individuals [24–27]. 
In either age group the condition can have detrimental effects on the cardiovascular 
system and other vital organs [12, 26, 28].
Systolic BP and PP are both increased in ISH, and are major predictors of heart 
disease. These haemodynamic parameters are associated with increased risk of 
myocardial infarction, left ventricular hypertrophy (LVH), renal dysfunction, 
stroke and cardiovascular mortality to a greater extent than DBP [29–31]. Some data 
from clinical trials suggest that even small elevations of SBP confer a significant 
risk of coronary heart disease [32]. The low DBP associated with ISH may lead 
to impaired tissue perfusion, particularly of the heart itself [29, 31]. In fact, ISH, 
which was long believed to be a normal and physiologically harmless state associ-
ated with the ageing process [30] has been shown to be a stronger predictor of 
cerebrovascular and cardiovascular events [32] as well as renal disease [29] than 
elevated DBP. A thorough understanding of the pathophysiology of ISH is necessary 
in order to manage the condition effectively and possibly reduce its negative effects 
on target organs.
Systolic BP has been shown to increase with age [33], a phenomenon that has 
been attributed to “natural” changes occurring in the arterial walls as the body 
ages. For this reason, most of the physiological mechanisms that are believed to 
be responsible for ISH are associated with the vascular ageing process [34]. This 
involves an interplay of several processes typically culminating in increased stiff-
ness of the central arteries [30, 31, 35, 36].
As the vascular system ages - usually from about the age of 50 [17, 30], the arte-
rial walls experience fatigue and the elastin fibres therein begin to fragment. This 
Hypertension subtype Day BP (mm Hg) Nigh BP (mm Hg)
Isolated Nocturnal Hypertension < 135/85 ≥ 120/70
Isolated Daytime Hypertension ≥ 135/85 < 120/70
Sustained 24-hour Hypertension ≥ 135/85 ≥ 120/70
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is associated with increased calcium deposition and subsequent media calcification 
[17]. In addition to this, more collagen fibres are deposited into this fragile wall. 
There is an accumulation of Advanced Glycation End products (AGEs), which pro-
gressively and irreversibly interlink with collagen and elastin fragments to form a 
complex matrix [36, 37]. Local inflammation occurs, characterised by the release of 
pro-inflammatory cytokines and enzymes including some metalloproteases which 
inhibit the production of Nitric Oxide (NO) an influential vasodilator substance, 
leading to endothelial dysfunction [35, 36, 38].
The pathophysiology of ISH in young individuals is thought to differ at least 
to some extent from the mechanisms described for the older population [24, 28]. 
In some young people, ISH develops following a hyperkinetic pre-hypertensive 
state which is associated with an increase in sympathetic stimulation. This is 
associated with adrenergic activation with the release of norepinephrine. In 
these individuals, an increase in resting heart rate and cardiac output leads to 
an acceleration of arterial stiffness with an isolated increase of SBP [28]. The 
findings of McEniery et al. [39] in a study of individuals between 17 and 27 sug-
gest that indeed aortic stiffness is associated with ISH in young people, having 
similar pathophysiological implications as it does in the elderly. Some researchers 
have shown that an increase in stroke volume in certain young individuals is  
the major contributor to an elevated PP leading to premature aortic stiffening 
[26, 27, 28, 39]. Increased body fat in obese young adults could also be a contrib-
uting factor to isolated elevation of SBP as the former has been shown to be a 
strong predictor of aortic stiffness [24].
Another type of ISH is observed in young active, particularly athletic adults. In 
this group, the SBP and PP elevations are often isolated to the peripheral arteries 
(especially in the upper limbs), while central haemodynamics remain normal 
[28, 40]. This phenomenon has been attributed to the effects of exercise-related 
bradycardia on stroke volume; which is thought to increase PP by exaggerating 
the amplification of the pressure wave [28, 40, 41]. This type of ISH is arguably 
considered spurious and somewhat ‘non-detrimental’ by most researchers  
[28, 42–44] since most risk is often associated with central rather than peripheral 
abnormalities [27].
1.2 Ambulatory isolated systolic hypertension
Early studies into ambulatory ISH seemed to suggest that ISH was a form of 
“white coat” hypertension that was not sustained during day to day activities 
outside a clinical setting [45, 46]. The work of Staessen et al. [10] compared the pre-
dictive ability of ABPM over conventional BP measurement in older ISH patients, 
and found that ambulatory SBP was a more superior predictor of cardiovascular 
risk than conventional SBP. Later research using improved technology for ABPM 
showed that while this may be true to some extent, sustained and masked forms of 
ISH are also prevalent, particularly in the elderly population [47]. Over time, ABPM 
became more useful in investigating ISH from several angles. It has been used to 
investigate postprandial hypotension in elderly ISH patients [48]. Saladini et al. [49] 
investigated the future risk of sustained hypertension in young, sporty ISH patients 
diagnosed by ABPM. These studies either used ABPM in people already diagnosed 
with ISH using conventional BP monitoring or diagnosed ISH with ABPM using 
only 24-hour BP. None these studies identified the ambulatory ISH subtypes. 
Therefore, a possibility exists that with ambulatory BP monitoring, different types 
of ISH can be identified.
With this gap in the current literature, we designed a study using ambulatory 
BP monitoring, with the aim of identifying different ambulatory ISH subtypes, 
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determining their prevalence and investigating whether these subtypes are associ-
ated with preclinical cardiovascular pathology in a population of African ancestry.
2. Methods
2.1 Study group
Participants of African ancestry were recruited from Soweto, a township in the 
southwest of Johannesburg. The lower age limit for the participants was 18 years 
and there was no upper age limit. Based on their conventional and ambulatory BP 
measurements were divided into the following six groups:
i. Normotensives (NT). Those with normal daytime and normal night-
time ambulatory BP (daytime BP < 135/85 mm Hg and nighttime 
BP < 120/70 mm Hg).
ii. Hypertensives (HT). Those with increased daytime BP and increased night-
time BP (daytime BP ≥ 135/85 mm Hg and night-time BP ≥ 120/70 mm Hg).
iii. Conventional isolated systolic hypertensives (ISHC). Those with increased 
conventional systolic BP and normal conventional diastolic BP (systolic 
BP ≥ 140 mm Hg and diastolic BP < 90 mm Hg).
iv. Twenty four-hour ambulatory isolated systolic hypertension (ISH24). Those 
with increased 24-hour systolic BP and normal 24-hour diastolic BP (24-hour 
systolic BP ≥ 130 mm Hg and 24-hour diastolic BP < 80 mm Hg).
v. Night-time isolated systolic hypertensives (ISHN). Those with increased 
night-time systolic BP and normal night-time diastolic BP (night-time 
systolic BP ≥ 120 and night-time diastolic BP < 70 mm Hg).
vi. Daytime isolated systolic hypertensives (ISHD). Those with increased 
daytime systolic BP and normal daytime diastolic BP (daytime systolic 
BP ≥ 135 mm Hg and daytime diastolic BP < 85 mm Hg).
2.2 Blood pressure measurement
Participants were invited to visit the Human Nutrition Clinic at the School of 
Physiology, Wits Medical School where conventional BP was measured using an 
automated pressure monitor (Omron, Kyoto, Japan) after they were allowed to rest 
for 10 minutes. Twenty four-hour ambulatory BP was measured using a 24-hour BP 
monitor (Spacelab, model 91207). Monitors were set to measure BP every 15 min-
utes from 06:00–22:00 and every 30 minutes thereafter until 06:00 the next morn-
ing. On average, participant bedtime was 19:00 and wake up time was 05:00. Based 
on this, the 09:00–19:00 and 23:00–05:00 intervals were used to define daytime and 
night time respectively.
2.3 Anthropometric measurements
Anthropometric measurements were taken while the participants were barefoot 
and wearing lightweight indoor robes. Weight was measured using a floor scale 
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(Health o meter® Professional, USA) and was recorded to the nearest 0.1 kg. For 
this measurement, the participant was asked to stand upright on the middle of the 
scale with their weight distributed evenly between both feet. Height was measured 
to the nearest 0.1 m using a wall-mounted stadiometer (Seca®, Germany), with 
the participant standing upright and the headpiece of the stadiometer was placed 
horizontally on the vertex (highest point) of the participant’s head and the cor-
responding reading was recorded. Body Mass Index (BMI) was calculated as weight 
in kilogrammes divided by the square of the height in metres. Participants with 
a BMI ≥ 25 kg/m2 were considered overweight, and those with a BMI ≥ 30 kg/m2 
were considered obese. Waist circumference was measured in at the end of normal 
expiration using an inextensible measuring tape aligned parallel to the floor at the 
narrowest point between the costal margin and the upper iliac crest.
2.4 Pulse wave velocity measurement
A high fidelity tonometer interfaced with a SphygmoCor computer software 
(AtCor Medical Pty. Ltd., West Ryde, New South Wales, Australia - version 9.0) was 
used to perform pulse wave assessments of pulse wave velocity (PWV), an index 
of arterial stiffness. Participants were allowed to rest in the supine position for 
15 minutes prior to assessment. Using an inextensible measuring tape, distances (in 
mm) between the relative sampling sites (femoral and carotid) and the suprasternal 
notch were measured. The difference between the two distances was considered as 
the pulse wave distance. Applanation tonometry was then used to record sequential 
wave forms at the participant’s dominant carotid and femoral regions. A three lead 
chest ECG was performed concurrently with the waveform sampling in order to 
assess the time differences in the generation of the waveforms. The pulse transit 
time was defined as the average of 10 consecutive beats. The PWV was automati-
cally calculated as the difference between the aforementioned distances (i.e. the 
pulse wave distance) divided by the pulse transit time.
2.5 Echocardiography
Echocardiography was used to determine the left ventricular mass index for 
the participants. All echocardiographic measurements were carried out by an 
experienced technician using an echocardiogram - the Acuson SC2000 Diagnostic 
Ultrasound System (Siemens Medical Solutions USA, Inc.) linked to a 10-MHz 
linear array transducer and electrocardiogram. Participants were asked to lie in 
the left lateral decubitus position. M-mode images were taken at a frame rate of 
>110 frames per second. M-mode echocardiography of the short axis of the heart 
was obtained as close to the tip of the mitral valve as possible using the parasternal 
long axis view (2D). The resulting images were used to measure left ventricular 
dimensions only when the endocardial surfaces of the septal and posterior walls, 
as well as both the left and right septal surfaces, could be clearly seen. Wall dimen-
sions, namely the Left Ventricular Internal Diameter at end Diastole (LVIDD), 
the Posterior Wall Thickness in Diastole (PWTD) and the Interventricular Septal 
Thickness in Diastole (IVSTD) were obtained from M-mode images. Left ventricu-
lar mass values were indexed for body.
3. Statistical analysis
Database management and statistical analyses were performed with SAS 
software, version 9.4 (The SAS Institute Inc., Cary, North Carolina, USA). Data 
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from individual subjects were averaged and expressed as mean ± SD for con-
tinuous variables and categorical variables were expressed as percentages. The 
differences between the means was calculated using the General Linear Model 
(GLM) and adjustments were made for the following covariates; age, gender, 
BMI, alcohol intake and cigarette smoking. A p value <0.05 was considered sig-
nificant. The Receiver Operator Characteristics (ROC) curve analysis was used 
to determine how well the different subgroups of ISH would predict an increased 
PWV and LVMI. The ROC curve analysis is used in clinical prediction to assess 
how well a test can discriminate between absence or presence of a condition. The 
analysis yields a curve of sensitivity versus 1-specificity, where the Area Under 
the Curve (AUC) is a measure of predictive power of the test to a maximum of 1 
[50]. The closer the AUC is to 1, the greater the ability of the test in question to 
discriminate whether the presence of a condition is associated with a change in a 
given parameter [50].
4. Results
Table 1 shows the demographic, general and clinical characteristics of the 
population under study. Of the 549 participants, 41 (7.5%) had ISH as measured 
by conventional means (ISHC). This figure is similar to those obtained for the 
ambulatory sub-types of ISH, namely 24-hour, Night-time and Daytime ISH which 
had 39 (7.1%), 42 (7.7%) and 41 (7.5%) participants respectively. Systolic-diastolic 
hypertension was observed in 161 (29%) of the participants. The mean age of 
the population was 45.3 ± 18.5 years and the ISHC group was significantly older 
(65.3 ± 13.5 years) than both normotensives (39.7 ± 17.6 years) and hypertensives 
(52.1 ± 15.5 years). There were slight reductions in average age within the other 
ISH subtypes, with ISH24 at 57.8 ± 20.1 years, ISHN at 55.4 ± 24.6 years and ISHD 
at 53.7 ± 20.9 years. We observed that all the ISH subgroups had greater propor-
tions of female participants than the normotensive or hypertensive groups [51]. 
Anthropometry revealed significantly higher waist circumference in the ISHC 
group than in the normotensives, this was also true for all the other ISH subgroups 
albeit of no known significance. In addition to this, the overall population was 
overweight with a BMI of 29.1 ± 7.8 kg/m2. Both ISHC and hypertensives were obese 
(BMI of 31.4 ± 7.5 kg/m2 and 30.9 ± 7.5 kg/m2 respectively), the former group hav-
ing a significantly higher BMI than the normotensives (BMI = 28.0 ± 7.7 kg/m2).  
The average SBPC of the ISHC group (153.1 ± 11.7 mm Hg) was higher than that of 
the hypertensive group (149.6 ± 20.3 mm Hg), and significantly higher than that 
of the normotensives (129.7 ± 21.4 mm Hg). Overall, the SBPC values for all ISH 
sub-types were high. Conventional ISH had an average DBPC of 83.5 ± 4.8 mm Hg, 
significantly higher than that of normotensives (77.6 ± 7.2 mm Hg) and significantly 
lower than that of hypertensives (98.6 ± 8.4 mm Hg). Similarly, 24-hour, night-time 
and daytime ISH all had conventional diastolic blood pressures below those of 
hypertensives but above those of normotensives. All sub-types of ISH had higher 
pulse pressure values than both normotensives and hypertensive groups, signifi-
cantly so for those participants with ISHC (PP = 69.7 ± 12.3 mm Hg).
Tables 2 and 3 show the ROC curve analysis of the relationships between the 
sub-types of ISH and cardiovascular target organ changes. All subtypes of ISH were 
significantly associated with increased PWV and LVMI. Conventional ISH strongly 
predicts arterial stiffness and left ventricular hypertrophy, with area under the 
curve (AUC) values of 0.88 ± 0.03 (CI: 0.83 to 0.93) and 0.86 ± 0.03 (CI: 0.88 to 
0.92), respectively. Daytime ISH was shown to be a strong predictor of both (PWV 






















Total sample population NT ISHC ISH24 ISHN ISHD HT
Numbers (%) 549 347 (63.2) 41 (7.5) 39 (7.1) 42 (7.7) 41 (7.5) 161 (29.3)
Age (years) 45.3 ± 18.5 39.7 ± 17.6 65.3 ± 13.5 57.8 ± 20.1 55.4 ± 24.6 53.7 ± 20.9 52.1 ± 15.5*#
Female gender (%) 36.6 34.0 51.2 51.3 47.6 56.1 38.5
Waist C (cm) 90.04 ± 16.01 87.02 ± 16.05 98.11 ± 14.27 90.04 ± 60.01 96.86 ± 18.11 95.87 ± 16.23 94.40 ± 14.67*
BMI (kg/m2) 29.1 ± 7.8 28.0 ± 7.7 31.4 ± 7.5 31.2 ± 8.1 30.9 ± 9.3 31.4 ± 8.9 30.9 ± 7.5*
Smokers (%) 15.1 14.4 19.5 15.4 14.3 21.9 15.5
Alcohol usage (%) 23.3 19.6 24.4 20.5 33 26.8 31.1
SBPC (mm Hg) 129.7 ± 21.4 117.6 ± 11.8 153.1 ± 11.7 151.9 ± 21.7 142.7 ± 23.8 147.7 ± 22.4 149.6 ± 20.3*
DBPC (mm Hg) 84.1 ± 12.0 77.6 ± 7.2 83.5 ± 4.8 88.7 ± 11.9 85.6 ± 10.5 86.7 ± 12.0 98.6 ± 8.4*#
PP (mm Hg) 45.5 ± 14.9 40.1 ± 12.0 69.7 ± 12.3 63.2 ± 16.2 57.1 ± 17.2 61.0 ± 18.0 51.1 ± 17.3*#
BMI, body mass index; NT, Normotensive; ISHC, Conventional Isolated Systolic Hypertension; ISH24, 24 Hour Isolated Systolic Hypertension; ISHN, Night-time Isolated Systolic Hypertension; ISHD, 
Daytime Isolated Systolic Hypertension; HT, Hypertensive; PP, Pulse Pressure; DBPC, Conventional Diastolic Blood Pressure; SBPC, Conventional systolic blood pressure; Waist C, Waist Circumference. 
Data is presented as mean ± SD or percentage.  
* depicts significant difference between ISHC and NT,  
# depicts significant differences between ISHC and HT. P < 0.05 for all significant differences.
Table 1. 
Demographic and clinical characteristics of participants according to blood pressure status.
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(AUC values all exceeding 0.8). The pattern of association and the significance was 
maintained even after adjusting for confounding variables.
Figures 1 and 2 shows data of PWV and LVMI respectively expressed as 
adjusted means ± SD. For both PWV and LVMI, there was no significant differ-
ence in the PWV of the different ISH subtypes and none of the ISH subtypes was 
ISH subtype AUC CI
ISHC 0.88±0.03 0.83 to 0.93
ISH24 0.77±0.04 0.68 to 0.86
ISHN 0.78±0.04 0.70 to 0.85
ISHD 0.83±0.05 0.74 to 60.92
AUC, area under the curve; CI, confidence intervals; ISHC, conventional isolated systolic hypertension; ISH24, 24 
hour Isolated systolic hypertension; ISHN, Night-time isolated systolic hypertension; ISHD, Daytime isolated systolic 
hypertension P < 0.05 for all associations. Adjustments were made for age, gender, BMI, the use of antihypertensive 
medication, smoking and alcohol consumption.
Table 2. 
ROC curve analysis of the relationship between ISH and PWV.
ISH subtype AUC CI
ISHC 0.86±0.03 0.88 to 0.92
ISH24 0.76±0.03 0.67 to 0.86
ISHN 0.71±0.05 0.62 to 0.80
ISHD 0.80±0.06 0.68 to 0.09
AUC, area under the curve; CI, confidence intervals; ISHC, conventional isolated systolic hypertension; ISH24, 24 
hour Isolated systolic hypertension; ISHN, Night-time isolated systolic hypertension; ISHD, Daytime isolated systolic 
hypertension. P < 0.05 for all associations. Adjustments were made for age, gender, BMI, the use of antihypertensive 
medication, smoking and alcohol consumption.
Table 3. 
ROC curve analysis of the relationship between ISH and LVMI.
Figure 1. 
Comparison of PWV of ISH subgroups, the hypertensives and the normotensives. This figure shows data of 
PWV expressed as adjusted means ± SD. The differences between the means was calculated using the general 
linear model and adjustments were made for the following covariates; age, gender, BMI, alcohol intake and 
cigarette smoking. There was no significant difference in the PWV of the different ISH subtypes and none of the 
ISH subtypes was significantly different from the hypertensives. However, the PWV of all the ISH subtypes and 
hypertensives was significantly higher than that of the normotensives. * = p value <0.05.
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significantly different from the hypertensives. However, the PWV and LVMI of all 
the ISH subtypes were significantly higher than that of the normotensives.
5. Discussion
In the present study, we determined the general characteristics of ISH and 
went on to divide it into four subtypes namely Conventional ISH, 24-hour ISH, 
Night-time ISH and Daytime ISH. We proceeded to investigate the associations 
between each of these subtypes with PWV and LVM. We further investigated the 
extent to which each of the ISH subtypes predicted the target organ changes men-
tioned. The results of the present study show that 7.5% of the cohort had ISHC 
and the same percentage had Daytime ISH. Night-time ISH was found in 7.7% 
of the population, while 7.1% of the participants had 24-hour ISH. Furthermore, 
our findings show that all subtypes of ISH are significantly associated with 
increased PWV and LVMI in measures comparable to general hypertension, The 
percentage of participants with ISHC in our study is consistent with the work of 
Gupta et al., [52] who found a similar (7.78%) prevalence of the condition follow-
ing their study of office workers in a North Indian town. Huang et al., [53] also 
found a similar prevalence of ISH (7.6%) in a Chinese study. However, all these 
studies used only conventional BP measurements to determine the prevalence of 
ISH. Hence our study is the first to identify the three ISH subtypes identified by 
ambulatory BP monitoring.
5.1 Determinants of ISH
5.1.1 Socio-economic status
Our and other studies indicate that the prevalence of isolated systolic hyperten-
sion averages around 8% across populations whether measured by conventional 
or ambulatory BP techniques. However, Ntuli, et al. [54] investigated a population 
ethnically similar to our study cohort and their study revealed a much higher 
Figure 2. 
Comparison of the LVMI of the ISH subtypes, the normotensives and the hypertensives. This figure shows data 
of LVMI expressed as adjusted means ± SD. The differences between the means was calculated using the general 
linear model and adjustments were made for age, gender, BMI, alcohol intake, cigarette smoking and presence 
of diabetes. There was no significant difference in the LVMI of the different ISH subtypes and none of the ISH 
subtypes was significantly different from the hypertensives. However, the LVMI of all the ISH subtypes and 
hypertensives was significantly higher than that of the normotensives. * = p value <0.05.
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prevalence of ISHC (21%). The most likely explanation for this is the socioeconomic 
difference between their sample population and ours. The study by Ntuli et al. [54] 
was conducted in rural Limpopo (Dikgale), where unemployment and poverty 
is high and there is limited access to adequate healthcare [54–56]. Ntuli’s study 
indicates that socio-economic factors could play a role in the prevalence of ISH. 
Socioeconomic factors have been implicated in contributing to the high prevalence 
of hypertension in developing countries [57, 58], and it would not be surprising that 
ISHC would follow the trend.
5.1.2 Age
The mean age of participants in the present study (45.3 years) was similar 
to that of subjects in the study by Ntuli et al. [54] (44.2 years). Gupta et al. [52] 
did not report a mean age for their population which was limited to the working 
age-group under 58 years, while Huang et al. [53] carried out their investigation 
on participants in the 35–74 age group [52, 53]. The bulk of studies on ISHC have 
been focused on specific age groups, usually the young (under 35 years of age) or 
the old (over 50 years old) [27, 49, 59, 60] unlike our population which included all 
consenting persons over the age of 18. While several studies in recent years have 
shown that the condition is not at all restricted to the older population [25–27], 
the relatively high average age associated with ISH (especially the conventional 
subtype) in our study is consistent with the findings of a number of researchers and 
with the widely accepted notion that ISH is predominant and naturally occurring in 
the elderly population [1, 16, 18, 30, 61]. A study by Huang et al. [53] also showed 
an increase in ISHC with age.
Martins et al. [62] observed an increase in PP and SBP from the age of 45 
upward in their analysis of data from the NHANES. Indeed, the most commonly 
described pathophysiological mechanism for ISH involves changes occurring to 
the large arteries owing to ageing [13]. With age progression, elastin in the media 
decreases, leading to a fragmented media [13, 18] which is susceptible to calcium 
and lipid accumulation. Along with this media calcification occurs the accumu-
lation of smooth muscle cells within the intima, collagen cross linking occurs 
and all this leads to the thickening and fibrosis of the arterial wall [13, 18, 43]. 
These changes culminate in arterial stiffness, an increased wall-to-lumen ratio 
and a reduced cross-sectional area of the lumen of the greater arteries [13, 37, 
63]. Due to poor compliance, the large arteries fail to expand and subsequently 
recoil effectively in systole and diastole of the cardiac cycle, respectively. There 
is a resultant increase in aortic PP and PWV. Consequently, the reflected wave 
which would normally return during diastole, returns during late systole and 
augments systolic pressure; SBP increases while the DBP decreases [43, 63]. In 
line with this, we observed higher values of average SBPC in the ISH groups than 
in the normotensive group, and these were comparable to that of hypertensive 
participants. This was coupled with relatively low DBPC for all ISH sub-types 
when compared to the hypertensive group. By definition, PP is the difference 
between SBP and DBP, thus its normal value is approximately 40 mm Hg [64]. 
Pulse Pressure values exceeding 60 mm Hg are associated with target organ 
damage which may or may not be asymptomatic [3]. In the present study, PP was 
markedly increased in participants with ISHC, with an average of 69.7 mm Hg. 
Wallace et al. [65] also observed similar elevated SBP and PP (67 mm Hg) in their 
ISHC group. This finding was as expected based on the definition and underly-
ing physiology of the condition [16, 18, 61] since PP is the difference between 
systolic and diastolic BPs; and an increase in the former and/or decrease in the 
latter would raise PP.
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5.1.3 Obesity
In general, all the ISH groups in this study were obese. Average BMI values 
ranging from 30.9 to 31.4 were recorded for these groups, all of which exceed the 
obesity threshold of 30 for BMI [66]. The role of obesity as a risk factor for ISH is 
well documented [25, 35, 57, 63, 67]. Erhun et al. [68] observed the highest preva-
lence of ISH among the extremely obese group in their study. The ISH subgroup in 
the research by Grebla et al. [24] was overweight, and these authors suggested that 
obesity may be an important determinant of ISH in young adults [25]. A study by 
Nemes et al. [69] showed that obesity is associated with increased arterial stiffness 
and that this is true even for young obese adults, whose arterial stiffness they found 
comparable to that of elderly non-obese individuals. Although all of these studies 
investigated obesity in ISH by conventional BP measurement, their findings may 
extend to all the ambulatory subtypes of the condition as well. Our results show that 
in all participants with any forms of ISH, arterial stiffness as measured by PWV was 
increased in comparison to normotensives.
Several mechanisms have been described that may explain the role of obesity in 
ISH. Hyperinsulinaemia and insulin resistance, which are both strongly associated 
with obesity [70], may mediate aortic stiffness through glycation of vascular wall 
proteins and subsequent increased cross-linking [69]. Insulin has also been associ-
ated with smooth muscle hypertrophy and increased endothelial dysfunction of 
large arteries likely resulting from oxidant stress, causing increased susceptibility 
to atherosclerosis [69, 71]. One other significant mechanism that has been impli-
cated in the relationship between obesity and ISH is the activity of leptin [69]. 
Hyperleptinaemia is associated with endothelial dysfunction in obese individuals 
[72], which is an underlying cause of arterial stiffness. Schutte et al. [73] reported 
a strong negative correlation between leptin and arterial compliance coupled with 
a strong positive relationship between leptin and SBP as well as leptin and PP in 
obese/overweight hypertensive African women. The high-leptin state of over-
weight/obese women in our study population, which was predominantly African, 
has been previously described [74] and may play an important role in ISH.
5.2 Isolated systolic hypertension target and target organ changes
5.2.1 Arterial stiffness
We measured PWV by applanation tonometry, a minimally invasive method 
which is widely recognised as the ‘gold standard’ in the determination of arterial 
stiffness [65, 75]. As far as we know there are no studies which have investigated 
PWV in ambulatory subtypes of ISH, however, the general association of ISHC 
with arterial and aortic stiffness has been reported [65, 76, 77]. Antza et al. [77] in 
their study of arterial stiffness in ISHC observed an increase in arterial stiffness in 
patients with the condition, and suggested that ISHC may have a role to play in large 
artery arteriosclerosis.
This observation can be explained in terms of the haemodynamic changes 
associated with ISH. Since ISH is characterised by elevated systolic and pulse pres-
sures, these parameters exert increased mechanical stress on the arteries over time, 
leading to elastin fragmentation and subsequent calcification, collagen deposition 
and smooth muscle cell hypertrophy [34, 37, 76]. In addition to this, endothelial 
dysfunction associated with the shear stress also triggers the inhibition of NO 
production and the release of pro-inflammatory cytokines and growth factors such 
as TGF-β [31, 34, 65]. These augment arterial damage by promoting smooth muscle 
cell hypertrophy and the increased production of extracellular matrix proteins; 
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moreover, TGF-β inhibits the activity of those metalloproteases which would other-
wise assist by breaking down the collagen build-up, such as MMP-9 [38]. All these 
factors culminate in arterial stiffening of mainly the central arteries. In essence, ISH 
speeds up the rate of arterial ageing and increases arterial stiffness, thereby leading 
to its own exacerbation in a vicious cycle [65]. Several scholars agree that the causal 
relationship between arterial stiffness and ISH is bidirectional [31, 34, 38].
With this in mind, it is not surprising that we observed significantly elevated 
PWV in all subtypes of ISH when compared to normotensives. Of interest, is that 
all ISH groups had an increase in PWV that is comparable to that of the sustained 
hypertensive group. This suggests that the arterial damage caused by the ISH groups 
may equal arterial stiffness arising from sustained hypertension in this population. 
This is contrary to our expectation. We expected the PWV of the ISH24 to be higher 
than that of the other groups due to the cumulative effects of a high systolic BP that 
is sustained over a 24-hout period. The explanation for this apparent discrepancy 
is that 24-hour BP is a combination of both daytime and night-time BP. Since BP 
decreases at night, that decline in nocturnal BP may have a damping effect on the 
*overall effect of ISH24 on arterial stiffness.
When we used ROC curve analysis to determine how well the different sub-
groups of ISH would predict an increased PWV in this population, our results 
indicate that all ISH subtypes predict PWV. Conventional ISH was the strongest 
predictor of arterial stiffness with an AUC of 0.88 followed by ISHD at 0.83. In this 
respect, daytime BP is emerging as the best predictor of ISH in this population as 
both conventional and daytime ambulatory BP are measured during the day. This is 
due to the 24-hour pattern of BP in which BP increases during the day and decreases 
at night. Our results indicate that the increase in daytime systolic BP in people 
with ISH is exaggerated, resulting in a high PP of 70 mmHg, which is 30 mm Hg 
the normal value of 40 mm Hg. This is PP value is higher than that of people with 
sustained hypertension. The same pattern was observed in people with ISHD. As 
discussed earlier, PP is an independent risk factor for vascular disease. This explains 
why ISHC and ISHD which have the highest PP, are the strongest predictors of 
arterial stiffness. Even though ISHN predicts arterial to a lesser extent than ISHC 
and ISHD, it is still a strong predictor of arterial stiffness with an AUC of 0.78. This 
highlights the importance of this study which is the first to discover the existence of 
this clinical entity.
5.2.2 Left ventricular hypertrophy
Left ventricular mass index has been used as an indication of LVH, a major 
independent predictor of cardiovascular mortality and morbidity [78–80]. We used 
echocardiography, a well-accepted, efficient and non-invasive tool for the estima-
tion of LVMI [79, 80]. In this study, there were no clear differences in LVMI values 
obtained for the ambulatory ISH sub-types (ISHD, ISHN and ISH24), suggesting 
that there are no major differences in the development of LVH among these three 
subtypes; although the extent of cardiac damage they caused is similar to that 
associated with hypertension. This implies that even if diastolic BP can be normal, 
the impact of systolic BP alone is significant has a significant impact on cardiac 
morphology. The premature return of the reflected wave in ISH is probably the 
most significant cause of LVM increase [81] in this condition. The augmentation of 
SBP by the reflected wave results in an increased afterload to the left ventricle. As 
the left ventricle adapts to the increased workload, concentric hypertrophy of sur-
rounding tissue occurs, resulting in thickening and increase in mass of the left ven-
tricle wall [37]. Poor coronary perfusion owing to low DBP may also exacerbate the 
effects of increased LVM in ISH as increased oxygen demand of the myocardium 
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becomes difficult to meet [82]. Our results bear some similarity to those obtained 
by Pearson et al. [83], who reported that ISHC patients exhibited increased LVMI 
arising from thickened septal and posterior walls of the left ventricle. Lip et al. 
[84] had related outcomes, they found that LVMI and other echographic param-
eters were similar between ISHC and full hypertension (SDH) groups. Our study 
adds significantly to this body of knowledge by showing that ISH has a number of 
subtypes which are as detrimental to cardiac pathology as both ISHC and sustained 
hypertension. Some research has shown that increased LVMI even within the “nor-
mal” range is clinically relevant i.e. it is associated with significant cardiovascular 
risk [85]. Since ISH increases the risk of LVH at least twofold, even the preclinical 
increases in LVM observed in this study may progress to cardiac pathology over 
time as the elevated SBP persists.
Most ISH studies in the past have been carried out on elderly participants, how-
ever, our results show that even after correcting for age the associations and predic-
tions remain unchanged, suggesting that ISH is just as detrimental to the elderly as 
it is to younger age groups with respect to left ventricle structure and consequently, 
cardiovascular function. Levy et al. [79] also found that the relationship between 
increased LVMI and cardiovascular morbidity and mortality was applicable to the 
middle-aged study group as much as the elderly study group, although their focus 
was not particularly on ISH. Obesity, which was identified in this ISH population, 
is thought to increase the risk of LVM and LVH by its tendency to attract other risk 
factors such as metabolic syndrome and diabetes mellitus [85]. Genetics also plays 
an important and complex role in the increase of LVM and development of LVH. 
So, the population under study - being predominantly black, may be at higher risk 
of LVH. Skelton et al. [86] reported a very high prevalence of increased LVM in an 
African-American population. This highlights the need for more studies to investi-
gate the impact of ISH subtypes to be investigated.
Similar to PWV, again ISHC and ISHD were the strongest predictors of increased 
LVMI according to ROC analysis (AUC = 0.86 and 0.80 respectively), followed 
by ISH24 (AUC = 0.76) and ISHN (AUC = 0.71). This confirms the impact of the 
increases in daytime systolic BP on cardiovascular organs. There is no comparable 
research on ISH subtypes predictive power on increased LVMI, however our results 
provide strong evidence that ISH subtypes, which were not known previous to this 
study, predict preclinical cardiac pathology similar to hypertension, indicating that 
these subtypes are clinical entities that require intervention.
6. Conclusion
Our overall findings are that there are three subtypes of ambulatory ISH 
(24-hour ISH, night-time ISH and daytime ISH) which had not been previously 
defined. Night-time ISH is the most prevalent form of ISH in this population. Most 
importantly our results indicate that all these ISH subtypes may be as detrimental 
to cardiovascular organs as hypertension as they all emerged as good predictors 
of elevated PWV and LVMI, which are markers of arterial stiffness and left ven-
tricular hypertrophy respectively. This highlights the importance of using both 
conventional and ambulatory BP techniques for the diagnosis ISH because current 
strategies that are limited to conventional BP monitoring, are incapable of detecting 
ambulatory isolated systolic hypertension subtypes. Moreover, since this data shows 
that night-time ISH is the most prevalent form of ISH, and it predicts both arterial 
stiffness and left ventricular hypertrophy, diagnosis of nocturnal ISH may be very 
essential in the management of BP related cardiovascular target organ damage.
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